Screening for mitochondrial toxicants in HepG2 cells.
$505,478N01FY2011ESNIH
Integrated Laboratory Systems, Llc, Research Triangle Park NC
Investigators
Abstract
The purpose of this contract is to provide support for the development of a high through-put screen for mitochondrial toxicants. These efforts are part of the Tox21 initiative.
View original record on NIH RePORTER →